[ad_1] The convalescent plasma therapy is no “magic bullet” to deal with coronavirus, and only large-scale controlled trials can ascertain its efficacy as part of the treatment strategy, top medical experts said on Monday, even as several states are considering the use of the therapy to treat critically-ill COVID-19 patients. …
Read More »
[ad_1] Naina MishraTribune News ServiceChandigarh, April 26 PGIMER evaluated the safety of Mycobacterium w (Mw) in four hospitalized patients with COVID-19 and found no short-term adverse effects of the drug in the pre-study phase. PGIMER has planned a prospective randomized trial in Chandigarh together with AIIMS-Delhi and AIIMS-Bhopal to study …
Read More »
[ad_1] When it comes to fighting the new coronavirus, more and more states in India are opting for “rapid tests” instead of traditional swab-based procedures, despite controversy surrounding their effectiveness, to dramatically increase the rate Of the tests. and evaluate more people with fewer symptoms. This after South Korea, which …
Read More »